Introduction
Inhibiting a vital enzyme involved in the replication cycle of a pathogen or a biochemical pathway is a common strategy employed in many drug discovery programs . 1 
Thus inhibitors of HIV protease, Angiotensin
Converting Enzyme (ACE) illustrate this strategy. ] , as will be shown later. The spectrum of K i values also indicate inhibitor selectivity to the various Opioid receptors ,viz.. the µ ,δ,κ . 21, 22 . Thus it is possible to selectively block either of the above mentioned receptor subtypes, so as to get the desired pharmacological response.
It is possible to go beyond the K i and free energy estimation to understand the intricacies of the thermodynamics of receptor-ligand interactions. In partcular, the binding free energy does not tell anything about the gradients of the chemical potentials of the ligand in the free and bound (to the receptor) states. All that we need to obtain this information is the binding assay data of the fractional inhibition of the receptor at various levels of inhibition, as a function of the equilibrium free ligand concentration.
In this work, we propose a thermodynamic method based on the analysis of the fractional inhibition f Vs concentration ( of the free ligand) data. The Concentration Derivative Product (CDP) will be defined as the product of f and it's concentration derivative. 
Formulation
In what follows, we assume the validity of reversible MichaelisMenten kinetics. This is valid for a large number of ligands in the drug scenario where the drug molecules bind reversibly to the receptor . This is also fulfills the pharmaco dynamics requirement of a physiological drug half life of 812 hours.
The MichaelisMenten rate law for the fractional loading or activity is
Where V m,, K M ,c denote the maximum activity, the Michaelis constant and the concentration of the inhibitor respectively. K M = (k 1 +k r ) / k 1, where k 1 , k 1 , k r are the forward and backward kinetic constants for binding and reaction respectively. 4 For our analysis involving inhibitors k r = 0., and K M = K i , the disassociation constant of the inhibitor. . To locate the maxium of CDP ,we differentiate it with respect to c and set it equal to zero,
and for MM kinetics, we get : On the other hand, the CDP max mirrors increasing affinity.In the following, we consider the application of this method to a number of diverse drug scenarios.
Application to Drugs : Results
Firstly we apply the methodology to a number of HIV protease Nevertheless, in every case f max = 0.3333, as is true for the wild strain.
We now look at the case of the same inhibitor (β Naltrexamine), but three subtypes of Opioid receptors. viz. the µ,δ,κ which have their natural substrates 21, 22 . The selectivity of binding to various receptors mentioned above is reflected in their K i values(see also Table. 2). Using this thermodynamic criterion, it is straight forward to show that:
. From Eq.7 it is obvious that the CDP equals the ratio of gradients of two chemical potentials. The numerator is the gradient of free inhibitor chemical potential with respect to c. The denominator is the gradient of the bound state chemical potential with respect to a molecular pair -probability p 11 . This pair probability p 11 is a Mean Field Pair probability given by p 11 = f 2 /2. We recall that to physically interpret this pair probability, we visualize the ligand molecules as if they are arranged on adjacent points (nearest neighbor points) of a lattice of receptors. It is to be noted that each receptor point has either single occupancy ( bound receptor )or none (vacant receptor site).This is analogous to the Ising model of ferromagnetism. It may be noted that the lattice model has a fair degree of success in explaining protein structure and dynamics . The HIV protease is known to be a homodimeric beta strand protein , with sites S1,S2,S3, S1',S2',S3', the sites being symmetrically placed. In future, one could visualize the concept of 'tethered ligands' 31 where in a pair of small ligands will act as an effective inhibitor. It is thus hoped that small molecule inhibitors( which will have enhanced oral availability) can make a ' dual ligand'. In searching for lead compounds, thus the molecular pair probability p 11 and the gradient of bound state chemical potential will become very useful quantities.
Minimizing The Interference Of Experimental Error
The error of estimating the CDP from experimental data is minimal at points near f max = 1/3 . By following the line of argument followed in a previous study( successfully employed in the study of adsorption 23 ), this fact can be rigorously proved. But we omit the details in the present study, and only present the numerical results. This is can also be seen from Figure. 
Concluding Remarks
Some brief comments are in order regarding the significance of CDP peaking at intermediate loading of f = 1/3. If we follow simple qualitative arguments, this has mainly origin in the configurational entropy of binding .
The role of configurational entropy in protein folding is well understood 3, 28 30 . For many proteins, the difference between entropy and enthalpic contributions leading to the native structure is about 14 kcal/mole 3 . For the drugs analyzed, the free energy change is of the same order ( see Tables   1,2 ). When the 'native structure ' (receptor in active confirmation ) is disrupted as a result of ligand (inhibitor) binding , we would expect the binding free energy released to be of the same order( viz. 14 kcal/mole ).
How much of the protein (receptor) conformation is distorted due to inhibition can be understood through a study of low frequency hinge vibrations of the receptor, before and after binding. This is because, the HIV protease has flap regions, which control the accesss of the ligand to the receptor. These flap vibrations contribute appreciably to the vibrationalentropy change following drug binding. We do not attempt to quantify this in the present study, but this can be an interesting topic of a future publication. Table 3 Universality in the thermodynamics of receptor ligand interactions at CDP 
